Avanir and Concert Pharmaceuticals Announce License Agreement to Develop and Commercialize Deuterium-modified Dextromethorphan for Disorders of the Nervous System ALISO VIEJO, Calif. and LEXINGTON, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results